MediWound has commenced a pivotal, multicentre Phase III VALUE trial to assess its bioactive debridement therapy, EscharEx, ...

Researchers have successfully uncovered the molecular mechanisms by which bacterial cellulose patches stimulate the regeneration of plant wounds.   - The regeneration process requires the activation ...

A study has elucidated the mechanism by which bacterial cellulose mediates plant tissue regeneration. The work has been ...

Recent research into bacterial cellulose patches may speed plants' recovery, improve grafting and help with preservation.

The skin serves as the body's primary defense against harmful microorganisms, toxins, and physical damage. However, severe ...

YAVNE, Israel - MediWound Ltd. (NASDAQ:MDWD), a biopharmaceutical company specializing in enzymatic therapies for tissue repair, has launched a Phase III clinical trial for its product EscharEx®, ...

Phase III trial to assess the efficacy and safety of EscharEx® for debridement and facilitation of active wound closure Interim analysis planned after 65% of patients complete treatment, expected in ...

MediWound , an Israeli developer of products to treat burns and wounds using non-surgical tissue repair, said on Wednesday it was starting a Phase III trial for its treatment for venous leg ulcers.

He told me about a patient who had recently benefited from his high blood pressure regulator herb and subsequently referred ...

2012). Wound healing is a dynamic process facilitating the regeneration or repair of broken tissue (Farahpour, Habibi, 2012). Normal wound-healing response begins with injury and is a cascading ...

Once the bone was safely back inside the man, doctors worked to stem off any infections, according to the report. For one month, the medical team gave antibiotics, irrigated the wound, changed the man ...